NCT05588180

Brief Summary

In assessing critically ill patients, an accurate assessment of a patient's volume status and whether they will respond to a fluid challenge with an increase in cardiac output is vital. 1 When hypovolemia is detected, volume expansion is utilized to enhance hemodynamics and restore normal blood pressure. 2 Hemodynamic tests (right atrial pressure, pulmonary artery occlusion pressure, and cardiac output ) are used to assess preload in critically ill patients, although these indexes are not necessarily reliable predictors of fluid status. According to the Starling law, fluid administration is hypothesized to boost cardiac output by raising preload, which describes a positive relationship between cardiac muscle fiber length and contractility. However, the Starling curve hits a plateau beyond its ascending leg, and additional fluid administration can be hazardous, leading to right ventricular overload and pulmonary edema Invasive or noninvasive techniques can be used to determine blood volume status. Assessments such as central venous pressure (CVP) and mean pulmonary artery pressure (mPAP) are both invasive procedures. Various factors influence CVP (including thoracic, pericardial, abdominal pressures, etc.). CVP can be used as a fluid management indication, although It can be misused to estimate blood volume or mislead methods for treatment. Dynamic indices such as stroke volume variation (SVV) and pulse pressure variation (PPV) are superior to static indices for assessing volume status. However, these dynamic indices are unreliable when a patient is ventilated with low tidal volume, such as acute respiratory distress syndrome (ARDS); the tidal volume is insufficient to change intrathoracic pressure significantly. Ultrasound (US) evaluation of the inferior vena cava (IVC) may help determine fluid status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

October 18, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 20, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2023

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2023

Completed
Last Updated

May 24, 2023

Status Verified

May 1, 2023

Enrollment Period

7 months

First QC Date

October 18, 2022

Last Update Submit

May 23, 2023

Conditions

Keywords

mechanically ventilated patientsFVD / FAD

Outcome Measures

Primary Outcomes (1)

  • MAP

    mean arterial blood pressure

    the first 48 hours postoperative

Secondary Outcomes (2)

  • the cutoff value of FVD/FAD reflecting FR

    the first 48 hours postoperative

  • PPV

    the first 48 hours postoperative

Study Arms (2)

Group (P)

ACTIVE COMPARATOR

Group (P) PPV guided group

Procedure: PPV

Group (F)

ACTIVE COMPARATOR

Group (F) FVD/FAD ratio guided

Procedure: FVD/FAD ratio guided

Interventions

Ultrasound-guided ratio

Group (F)
PPVPROCEDURE

PPV

Group (P)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients on mechanical ventilation

You may not qualify if:

  • cardiac arrhythmias
  • previously known significant valvular disease or intracardiac shunt
  • air leakage through chest drains
  • increasing intraabdominal pressure
  • norepinephrine infusion as it decreases PPV and SVV
  • peripheral vascular diseases
  • ARDS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fayoum University hospital

Al Fayyum, Faiyum Governorate, 63514, Egypt

Location

Related Publications (2)

  • Kalantari K, Chang JN, Ronco C, Rosner MH. Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int. 2013 Jun;83(6):1017-28. doi: 10.1038/ki.2012.424. Epub 2013 Jan 9.

  • Monnet X, Marik PE, Teboul JL. Prediction of fluid responsiveness: an update. Ann Intensive Care. 2016 Dec;6(1):111. doi: 10.1186/s13613-016-0216-7. Epub 2016 Nov 17.

Study Officials

  • Mohamed Hamed, M D

    Fayoum University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: group (F) FVD/FAD ratio guided
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ASSOCIATE PROFESSOR OF ANESTHESIA

Study Record Dates

First Submitted

October 18, 2022

First Posted

October 20, 2022

Study Start

October 18, 2022

Primary Completion

May 15, 2023

Study Completion

May 20, 2023

Last Updated

May 24, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

No plan to share data

Locations